Jungbunzlauer Suisse AG:企業の戦略・SWOT・財務情報

◆英語タイトル:Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4113
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Jungbunzlauer Suisse AG – Strategy, SWOT and Corporate Finance Report
Summary

Jungbunzlauer Suisse AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Jungbunzlauer Suisse AG (Jungbunzlauer), a subsidiary of Jungbunzlauer Holding AG, is a manufacturer and supplier of natural biodegradable food additives and ingredients for food, beverage, pet food, pharmaceutical and cosmetic industries. The company’s product portfolio includes citric acid, lactics, specialties, special salts, xanthan gum, gluconates and sweeteners. It also provides customer support services including technical and application based services, legal support, application research and other tailor-made solutions. Jungbunzlauer operates through its manufacturing facilities in Austria, Canada, France and Germany. The company, through its network of distributors, sells products across Europe, North America, South America, the Middle East, Africa and Asia Pacific. Jungbunzlauer is headquartered in Basel, Switzerland.

Scope

- Detailed information on Jungbunzlauer Suisse AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Jungbunzlauer Suisse AG in the form of a SWOT analysis
- An in-depth view of the business model of Jungbunzlauer Suisse AG including a breakdown and examination of key business segments
- Intelligence on Jungbunzlauer Suisse AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Jungbunzlauer Suisse AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Jungbunzlauer Suisse AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Jungbunzlauer Suisse AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Jungbunzlauer Suisse AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Jungbunzlauer Suisse AG: Company Overview 8
Jungbunzlauer Suisse AG: Overview and Key Facts 8
Jungbunzlauer Suisse AG: Overview 8
Jungbunzlauer Suisse AG: Key Facts 8
Jungbunzlauer Suisse AG: Key Employees 9
Jungbunzlauer Suisse AG: Key Employee Biographies 10
Jungbunzlauer Suisse AG: Major Products and Services 11
Jungbunzlauer Suisse AG: Company History 12
Jungbunzlauer Suisse AG: Locations and Subsidiaries 14
Jungbunzlauer Suisse AG: Key Competitors 15
Jungbunzlauer Suisse AG: Company Analysis 16
Jungbunzlauer Suisse AG: Business Description 16
Jungbunzlauer Suisse AG: SWOT Analysis 18
Jungbunzlauer Suisse AG: SWOT Overview 18
Jungbunzlauer Suisse AG: Strengths 18
Jungbunzlauer Suisse AG: Weaknesses 19
Jungbunzlauer Suisse AG: Opportunities 19
Jungbunzlauer Suisse AG: Threats 20
Jungbunzlauer Suisse AG: Corporate Financial Deals Activity 21
Jungbunzlauer Suisse AG: Financial Deals Overview 21
Jungbunzlauer Suisse AG: Targets and Partners 22
Jungbunzlauer Suisse AG: Top Deals 2014 – 2018YTD* 23
Jungbunzlauer Suisse AG: Mergers and Acquisitions 24
Jungbunzlauer Suisse AG: Recent Developments 25
Jungbunzlauer Suisse AG: News and Events Summary 25
Jungbunzlauer Suisse AG: Business Expansion 26
Jungbunzlauer Suisse AG: Regulatory and Legal Events 27
Jungbunzlauer Suisse AG: Research & Development 27
Jungbunzlauer Suisse AG: Strategy and Operations 28
Appendix 29
Contact Us 29
Methodology 29
About MarketLine 30

List of Tables
Table 1: Jungbunzlauer Suisse AG: Key Facts
Table 2: Jungbunzlauer Suisse AG: Key Employees
Table 3: Jungbunzlauer Suisse AG: Locations and Subsidiaries
Table 4: Jungbunzlauer Suisse AG: Key Competitors
Table 5: Jungbunzlauer Suisse AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Jungbunzlauer Suisse AG: Targets and Partners
Table 7: Jungbunzlauer Suisse AG: Top Deals 2014 - 2018YTD*
Table 8: Jungbunzlauer Suisse AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 9: Jungbunzlauer Suisse AG: News and Events Summary
Table 10: Jungbunzlauer Suisse AG: Business Expansion
Table 11: Jungbunzlauer Suisse AG: Regulatory and Legal Events
Table 12: Jungbunzlauer Suisse AG: Research & Development
Table 13: Jungbunzlauer Suisse AG: Strategy and Operations

List of Figures
Figure 1: Jungbunzlauer Suisse AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Jungbunzlauer Suisse AG: M&A Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Jungbunzlauer Suisse AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atterx Biotherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atterx Biotherapeutics Inc (Atterx), formerly ConjuGon Inc is a developer of novel products for prevention and treatment of antibiotic-resistant bacterial infections. The company develops and commercializes conjugation-based antibacterial technology. Its products include C-1205 and GN-4474. …
  • Direct Flow Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Direct Flow Medical Inc (Direct Flow) is a medical device company that develops novel transcatheter heart valve technologies. The company provides transcatheter aortic valve implantation device without contrast. It also provides direct flow medical system, a technology for controlled and rel …
  • Citius Pharmaceuticals Inc (CTXR):製薬・医療:M&Aディール及び事業提携情報
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • HDI-Global SE:企業の戦略・SWOT・財務分析
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Symbiotec Pharmalab Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Sotera Health LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Automatic Data Processing, Inc.:企業の戦略・SWOT・財務分析
    Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report Summary Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • KUKA AG (KU2):企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Leprino Foods Co:企業の戦略的SWOT分析
    Leprino Foods Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cedars-Sinai Medical Center-医療機器分野:企業M&A・提携分析
    Summary Cedars-Sinai Medical Center (Cedars-Sinai), formerly Kaspare Cohn Hospital is an academic and medical center that provides healthcare services for patients and medical professionals, and research and education services. The center offers treatments for various conditions such as abdominal pa …
  • 1-800-FLOWERS.COM, Inc.:戦略・SWOT・企業財務分析
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Omnicom Group Inc. (OMC):企業の財務・戦略的SWOT分析
    Omnicom Group Inc. (OMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Beijing Enterprises Holdings Limited:戦略・SWOT・企業財務分析
    Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company’s products include anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic …
  • Amgen, Inc.:企業の戦略・SWOT・財務情報
    Amgen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:企業の戦略・SWOT・財務情報
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • John Menzies plc:戦略・SWOT・企業財務分析
    John Menzies plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆